Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
Chinese Medical Journal ; (24): 2789-2794, 2014.
Article in English | WPRIM | ID: wpr-318535

ABSTRACT

<p><b>BACKGROUND</b>The purpose of this retrospective study was to compare the surgical outcomes of simple discectomy and instrumented posterior lumbar interbody fusion (iPLIF) in patients with lumbar disc herniation and Modic endplate changes. Our hypothesis was that iPLIF could provide better outcome for patients with refractory lumbar disc herniation and Modic changes (LDH-MC).</p><p><b>METHODS</b>Ninety-one patients with single-segment LDH-MC were recruited. All patients experienced low back pain as well as radicular leg pain, and low back pain was more severe than leg pain. Forty-seven patients were treated with discectomy and 44 were treated with iPLIF. The outcomes of both low back pain and radicular leg pain using visual analogue scale (VAS) as well as the clinical outcome related to low back pain using Japanese Orthopaedic Association (JOA) score were assessed before and 18 months after surgery, respectively.</p><p><b>RESULTS</b>Both low back and leg pain were significantly improved 18 months after simple discectomy and iPLIF. Compared to patients undergoing simple discectomy, low back pain was significantly reduced in patients undergoing iPLIF, but there was no significant difference in leg pain between two groups. Solid fusion was achieved in all patients who underwent iPLIF.</p><p><b>CONCLUSIONS</b>In patients with LDH-MC, iPLIF can yield significantly superior outcome on the relief of low back pain compared to simple discectomy. Simple discectomy can relieve radicular leg pain as efficient as iPLIF. Accordingly, iPLIF seems to be a reliable treatment for patients with LDH-MC and predominant low back pain.</p>


Subject(s)
Adult , Female , Humans , Middle Aged , Diskectomy , Reference Standards , Intervertebral Disc Displacement , General Surgery , Low Back Pain , General Surgery , Lumbar Vertebrae , General Surgery , Retrospective Studies , Spinal Fusion , Reference Standards
2.
Journal of Biomedical Engineering ; (6): 625-631, 2014.
Article in Chinese | WPRIM | ID: wpr-290703

ABSTRACT

Polydimethylsiloxane (PDMS) and hydroxyapatite (HA) were combined in our laboratory to fabricate an elastic porous cell scaffold with pore-forming agent, and then the scaffold was used as culture media for rat bone marrow derived mesenchymal stem cells (rBMSCs). Different porous materials (square and circular in shape) were prepared by different pore-forming agents (NaCl or paraffin spheres) with adjustable porosity (62%-76%). The HA crystals grew on the wall of hole when the material was exposed to SBF solutions, showing its biocompatibility and ability to support the cells to attach on the materials.


Subject(s)
Animals , Rats , Biocompatible Materials , Chemistry , Dimethylpolysiloxanes , Chemistry , Durapatite , Chemistry , Mesenchymal Stem Cells , Cell Biology , Porosity , Tissue Scaffolds
3.
Journal of Jilin University(Medicine Edition) ; (6): 140-142, 1999.
Article in Chinese | WPRIM | ID: wpr-414767

ABSTRACT

Objective :To study mutation of Ps3 gene and its relationship with histologic grade and Dukes' stage in colorectal cancer. Methods :PCR-SSCP was used to detect mutations of Ps3 in 30 colorectal cancer patients. Results: It was found that 6 mutations (20. 0%) in the coding region of P53 gene. One mutation was located in exon4; 5 mutations were located in exon 5; none of mutation was found in exon 2 and 3. According to the histologic grade of of colorectal cancer,the frequencies of P53 gene mutation were 1/8 (12. 5%) in the well differentiated and in the moderately differentiated as well,3/10 (30. 0%) in the poorly differenctiated and 1/4 (25.0%) in the undifferentiated. In clinic, the frequencies of P53 gene mutation were associated with Dukes stage: 1/10 (10. 0 % ) in B stage, 2/12 (16. 7%) in C Stage,3/8(37. 5%) in D stage. Conclusion:The mutation of P53 gene is related to Dukes' stage,and the P53 gene mutation hardly occurs in exon 2,3 in coloretal cancer.

SELECTION OF CITATIONS
SEARCH DETAIL